Top 200 #3
Quiz yourself by thinking what should be in
each of the black spaces below before clicking
on it to display the answer.
Help!
|
|
|
|
|
|
|
|
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
K+ Sparing Diuretic/Thiazide Combo | Dyazide (capsule); Maxzide (tablet) | Triamterene/ Hydrochlorothiazide | HTN, Edema | Tablet (Maxzide): 37.5/25 or 75/50mg Capsule (Dyazide): 37.5/25 or 50/25mg | Oral | Triamterene: 37.5-75mg QD HCTZ: 25-50mg QD Ped:N/A | show 🗑
|
||||||||||||||||
Diuretic | Lasix | Furosemide | HTN, Edema | show | Oral, IV, IM | 20-80mg TID-QID Ped: 1-2mg/kg/day | Anthanilic acid derivative and a potent diuretic that works by blocking the absorption of Na+ and Cl- in the kidney tubules, causing a profound increase in urine output
🗑
|
||||||||||||||||
ACE Inhibitor/ Thiazide Combo | Prinzide; Zestoretic | Lisinopril/ Hydrochlorothiazide | HTN | show | Oral | 10/6.25 – 80/50mg QD Ped:N/A | diuretic and an antihypertensive agent that lowers elevated blood pressure; ACE inhibitor
🗑
|
||||||||||||||||
ACE Inhibitor/ Ca2+ Channel Blocker | Lotrel | Amlodipine/ Benazepril | HTN | Capsules: 2.5/10, 5/10, 5/20, 5/40, 10/20, 10/40mg | show | 2.5/10-10/40mg QD Ped:N/A | Amlodipine: dihydropyridine Ca2+ channel blocker
Benazepril: nonsulfhydryl ACE inhibitor
🗑
|
||||||||||||||||
Beta-Adrenergic Blocker/Thiazide Combo; Cardioselective | Tenoretic | Atenolol/ Chlorthalidone | HTN | Tablets: 50/25 or 100/25mg | Oral | show | Atenolol: beta-blocking agent
Chlorthalidone: diuretic acting on the cortical diluting segment of the ascending limb of the loop of Henle; increase excretion of Na+ and Cl-
🗑
|
||||||||||||||||
Anticoagulant; Factor Xa inhibitor | Xarelto | Rivaroxiban | Deep Vein Thrombosis, Pulmonary embolism, Prophylaxis, Nonvalvular atrial fibrillation | Tablets: 10, 15, 20 mg | Oral | show | Rivaroxaban selectively inhibits factor Xa without the need of a cofactor (eg, anti-thrombin III) for activity.
🗑
|
||||||||||||||||
Anticoagulant; Low Molecular Weight Heparin | Lovenox | Enoxaparin | show | Inj. Soln.: 30mg/0.3ml, 40/0.4, 60/0.6, 80/0.8, 100mg/ml, 120/0.8, 150mg/ml | SubQ | 0.75-1.5mg/kg QD (30-150mg per dose) Ped: 0.5-1.5mg/kg every 12 hours | Low molecular weight heparin with anti-Factor Xa and anti-thrombin activities
🗑
|
||||||||||||||||
Anticoagulant; Thrombin Inhibitor | show | Dabigatran | Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism | Capsules: 75 or 150mg | Oral | 150mg BID Ped:N/A | Competitive, direct thrombin inhibitor which prevents thrombus development. It inhibits both free & clot-bound thrombin as well as thrombin-induced platelet aggregation
🗑
|
||||||||||||||||
Anticoagulant | Coumadin; Jantoven | Warfarin | show | Tablets: 1, 2, 2.5, 3, 4, 5, 6, 7.5, 10mg IV Powder for Soln. (Coumadin only): 5mg | Oral, IV | 1-10mg QD Ped:N/A | Blocks the regeneration of vitamin K epoxide, thus inhibiting synthesis of vitamin K-dependent clotting factors (2, 7, 9 and 10) and the anticoagulant proteins C and S
🗑
|
||||||||||||||||
show | Plavix | Clopidogrel | Prophylaxis, Thrombosis | Tablets: 75 or 300mg | Oral | 75mg QD Ped:N/A | Anticoagulant; prodrug that inhibits platelet aggregation by selectively & irreversibly binding to the ADP P2Y12 receptor on platelets
🗑
|
||||||||||||||||
Parenteral Electrolyte (K+ Supplement) | K-Dur; K-Tab; Klor-Con | show | Hypokalemia, Prophylaxis | K-Dur: 20 mEq ER tablet K-Tab: 10 mEq ER tablet Klor-Con: 20 or 25 mEq oral powder for soln., 8, 10, M10, M20 ER tabs | Oral, IV | 10-100 mEq once to five times daily Ped: Oral: 3-8 mEq/kg/day IV: 0.5-0.75 mEq/kg over 1-2 hrs | Electrolyte replenisher that aids in many physiological processes
🗑
|
||||||||||||||||
CNS Agent; Immune Suppressant | show | Glatiramer acetate | Relapsing remitting Multiple Sclerosis | Inj. Soln.: 20mg/ml | SubQ | 20mg QD Ped:N/A | Believed to modify immune processes or functions which are thought to be liable for MS pathogenesis. In vitro studies suggest that glatiramer specific suppressor T-cells are induced & activated in the periphery
🗑
|
||||||||||||||||
Colony Stimulating Factor; Hematopoietic | show | Pegfilgrastim | Febrile neutropenia in patients with non-myeloid malignancies, Prophylaxis | Inj. Soln.: 6mg/0.6ml | SubQ | 6mg once per chemo cycle (don’t administer between 14 days prior to & 24 hrs after admin of chemo) Ped:N/A | A colony stimulating factor that acts on hematopoietic cells by binding to specific cell surface receptors thereby stimulating proliferation, differentiation, commitment, and end cell functional actv’n
🗑
|
||||||||||||||||
show | Rituxan | Rituximab | Non-Hodgkins lymphoma, Rheumatoid Arthritis, Chronic Lymphoid Leukemia | Inj. Soln.: 10mg/ml | IV | 375mg/m(2), usually given as part of a scheduled regiment with other meds Ped:N/A | MAB that binds to antigen CD20, this disrupts the cell cycle of B-cells resulting in cell lysis and even apoptosis
🗑
|
||||||||||||||||
show | Aldactone | Spironolactone | HTN, Hypokalemia, Ascites, Edema, Aldoseronism | Tablets: 25, 50, 100mg | Oral | 25-400mg QD Ped:N/A | Renal competitive aldosterone antagonist; it inhibits the effect of aldosterone by competing for the aldosterone-dependent Na+/K+ exchange site in the distal tubule cells. This increases the secretion of H2O & Na+, while decreasing the excretion of K+
🗑
|
||||||||||||||||
ARB/Thiazide Combo | show | Irbesartan/ Hydrochlorothiazide | HTN | Tablets: 150/12.5, 300/12.5, 300/25 | Oral | 150/12.5-300/25mg QD Ped:N/A | ‘sartan: angiotensin II blocker
HCTZ: increases excretion of Na+ & Cl- (diuretic/antihypertensive)
🗑
|
||||||||||||||||
ARB/Thiazide Combo | Benicar HCT | Olmesartan/ Hydrochlorothiazide | show | Tablets: 20/12.5, 40/12.5, 40/25mg | Oral | 20/12.5-40/25mg QD Ped:N/A | ‘sartan: angiotensin II blocker
HCTZ: increases excretion of Na+ & Cl- (diuretic/antihypertensive)
🗑
|
||||||||||||||||
ARB/Thiazide Combo | Diovan HCT | Valsartan/ Hydrochlorothiazide | HTN | Tablets: 80/12.5, 160/12.5, 160/25, 320/12.5, 320/25mg | show | 160/12.5-320/25mg QD Ped:N/A | ‘sartan: angiotensin II blocker
HCTZ: increases excretion of Na+ & Cl- (diuretic/antihypertensive)
🗑
|
||||||||||||||||
ARB/Thiazide Combo | Hyzaar | Losartan/ Hydrochlorothiazide | HTN, Prophylaxis | show | Oral | 50/12.5-100/25mg QD Ped:N/A | ‘sartan: angiotensin II blocker
HCTZ: increases excretion of Na+ & Cl- (diuretic/antihypertensive)
🗑
|
||||||||||||||||
Diuretic; Thiazide | HCTZ | Hydrochlorothiazide | HTN, Edema | Tablets: 12.5, 25, 50mg Capsule: 12.5mg | Oral | show | Electrolyte reabsorption inhibitor (resulting in increased excretion of Na+ and Cl- in equal amounts)
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
scottamus123
Popular Pharmacology sets